Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Versant Ventures
Deal Size : $60.0 million
Deal Type : Series A Financing
Nexo Therapeutics Launches with $60 Million Series A Financing
Details : The financing will support Nexo’s platform that combines the power of covalent ligand discovery and chemical biology to unlock a pipeline of novel cancer therapies directed against previously intractable targets.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 26, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Versant Ventures
Deal Size : $60.0 million
Deal Type : Series A Financing